Screener
Pacific Biosciences of California PACB Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Pacific Biosciences of California’s reported figures.
Based on trailing twelve months.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
FAQ
- What is Pacific Biosciences of California's gross margin?
- Pacific Biosciences of California (PACB) reported gross margin of 36.4% in Q2 2026.
- How has Pacific Biosciences of California's gross margin changed year-over-year?
- Pacific Biosciences of California's gross margin increased by 70.2% year-over-year, from 21.4% to 36.4%.
- What is the long-term trend for Pacific Biosciences of California's gross margin?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's gross margin has grown at a -7.7% compound annual growth rate (CAGR), from 42.7% to 28.6%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Pacific Biosciences of California's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude